Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"

• Status: Recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

To evaluate if utilizing Telehealth medicine for access to HIV PrEP will engage more Black and Latino Men who have sex with Men (MSM)

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Vivent Health
• Collaborator: Gilead Sciences
• Treatments: Emtricitabine tenofovir alafenamide

Criteria

Inclusion Criteria:

1. HIV negative on any FDA approved HIV test within 10 days of starting PrEP 18 years and older

2. No medical or mental health comorbidity that would preclude participating in a clinical study as deemed by the study investigator

3. Able to understand and sign consent in English or with other language interpreter

4. Able to stay in the state catchment area of the license health care provider

5. No use of PrEP for more than 30 days in the last year

Exclusion Criteria:

1. HIV positive

2. If greater and equal to 50 years of age and Renal Glomerular Filtration Rate (GFR) <30 mg/g

3. <18 years of age

4. No access to Internet or devise for telehealth

5. Cis-gender Women